Navigation Links
Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.
Date:2/29/2008

Lauds Company for Healthcare Innovation, Creating Local Jobs

LAWRENCE, Mass., Feb. 29 /PRNewswire-FirstCall/ -- Fifth District Congresswoman Niki Tsongas visited local medical device manufacturer NxStage Medical, Inc., at the company's headquarters in Lawrence last week. NxStage Medical is a growing public company whose novel portable technology makes it possible for people with kidney failure to have hemodialysis treatment at home or where they travel, and on a more frequent basis.

Tsongas met with representatives of NxStage, was briefed on its technology, and toured the company's facilities in the renovated Heritage Place mill complex at 439 South Union Street.

"I was pleased to visit NxStage last week to learn more about the exciting products and technology being developed by this innovative employer," said Tsongas. "NxStage is a leader in the healthcare industry and its presence in Lawrence exemplifies the kind of ground-breaking enterprise that is flourishing here in the Fifth District while providing outstanding local jobs."

Tsongas also met and talked with 34-year-old Marblehead-resident and NxStage patient Vanessa Evans, who is a part-time Spanish teacher and mother of two children. Evans began in-center hemodialysis in 1996, but after having her first child, the time commitment and physical toll of her treatments became too burdensome. Evans began training on the NxStage System One so she could have dialysis on a more frequent basis at home, on her own schedule.

"I was moved by Vanessa's story, which illustrated the tremendous benefits that the products developed by NxStage provide for those suffering from chronic kidney disease," said Tsongas.

"We are grateful to Congresswoman Tsongas for taking the time to visit, learn about our technology, and hear our views on the importance of achieving more favorable Medicare reimbursement for daily home therapy, which is not only less costly to perform and more con
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. First Lady Laura Bush Visits AED/Netmark Malaria-Control Project in Ghana
2. CRH Medical Corporation announces substantial increase in patient visits
3. A Reminder to Parents: Early Dental Visits Essential to Childrens Health
4. Depression not discussed during rheumatoid arthritis doctor visits
5. Patient Safety Authority Visits Facilities for Information on Wrong-Site Surgery
6. Holiday Visits Nudge Many Towards Senior Housing Decision
7. Where vets served affects frequency of ER visits but not hospital stays
8. NFL Legend John Madden Visits Capitol Hill;
9. Dramatic Growth Projected in Visits by Elderly Patients to Emergency Departments Underscores Urgency of Medicare Physician Payment Fix
10. 3 Common Drugs Trigger Most ER Visits by Seniors
11. Out-of-hours doctors reluctant to do home visits, say patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...toImproveOverallOutcomesforLungCancer ,, WASH...CancerAlliance-California(LCA-CA)issuedits2ndAnnua...essmentofprogressbeingmadeagainstthislethaldisease...rAlliance(LCA),theonlynationalorganizationdedicate...vingwithoratriskforlungcancer. ,, (Photo: http:...
(Date:11/25/2009)... and Spanish . , , Researchers from the ...gnosis of certain ocular diseases that are very co...on and keratitis, by applying an existing optical ...n used for this purpose. , Scientists from the ...fected by one of these two pathologies, finding a ...
(Date:11/25/2009).... Kaplan, MD, FACP, a former Board Chair and one o...me Los Angeles Biomedical Research Institute at Ha...red by the American College of Physicians for his ...its April 22, 2010 meeting in Toronto, the America...th the Ralph O. Claypoole Sr. Memorial Award for D...
(Date:11/25/2009)... . , An innovative treatment for HIV patient...earchers has passed its first clinical trial with ...py customized for each individual patient, and was...titute of the MUHC in collaboration with Dr. R. Sk...ine made for the individual patient an "haute cou...
(Date:11/25/2009)...o new drugs for people, researchers say , ...dienes, natural lipid molecules found in soy, coul...cancer, California researchers have found. , T... pointed out that they could help explain why soy ..., In the study, Dr. Julie Saba, senior scientis...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2Health News:1 of LA BioMed's founders to be honored 2Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Natural Soy Component May Help Treat Colon Cancer 2
...rs could provide scientific baseline for anti-agin...ov. 19 (HealthDay News) -- Genetic biomarkers that...age have been identified by researchers at Califor...ode worms, microarrays that measure changes in gen...
... Cancer Society urges people to stop for a day, th...Day News) -- Everyone knows smoking is bad for you...rs for Disease Control and Prevention said that th...h levels of smoking-related health problems, death...
...E, Calif., Nov. 19 Accuray Incorporated,(Nasdaq: ...gery, announced today,that on November 14, 2008, t...,Market stating that it is not in compliance with ...2008. , Within 60 calendar days following re...
...ve approach could aid research, treatment, experts...s) -- U.S. researchers say they,ve developed a new...urvival of cancer-killing cells within the body. ,...m Stanford University School of Medicine reports. ...
... Tenn., Nov. 19 Arabesque, an imprint of Kimani P...00 to St. Jude Children,s Research Hospital(R) in ...ove & Hope. The donation was presented recentl...thors Sandra Kitt and Gwynne Forster attended to a...
...kthrough Technology Leaves Skin Consistently Smoot... 18 Body-sculpting technology with consistently s... has launched in the U.S. and is now available to ...po is a laser device for minimally invasive laser-...
Other Medicine News:Health News:Researchers ID Suite of Genes in Aging Process 2Health News:Smokeout '08: The Perfect Time to Quit 2Health News:Smokeout '08: The Perfect Time to Quit 3Health News:Smokeout '08: The Perfect Time to Quit 4Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 2Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 3Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 4Health News:Technique Tracks Cancer-Killing Cells 2Health News:Arabesque Books Donates $15,000 in Support of St. Jude in Conjunction With a New Fall Book Series 2Health News:Eleme Medical Launches SmoothLipo(TM) Body Shaping Treatment 2
(Date:11/25/2009)...FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalpro...ssystems,announcedtodaythatClintSeverson,chairmana...PiperJaffrayHealthCareConferenceonWednesday,Decemb...ewYorkPalaceHotelinNewYorkCity. ,, AboutAbaxis...blebloodanalysissystemsforuseinanyveterinaryorhuma...
(Date:11/25/2009)...l/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicecom...ivesurgicaltreatmentsforthespine,announcedtodaytha...,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfocu...ny,sproductsandwillincludecommentsfrommanagementfo...umbersare1-877-407-4018fordomesticcallersand1-201-...
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 1IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 2First Anniversary of New War on Cancer Marks Many Advances 52259 1First Anniversary of New War on Cancer Marks Many Advances 52259 2First Anniversary of New War on Cancer Marks Many Advances 52259 3First Anniversary of New War on Cancer Marks Many Advances 52259 4First Anniversary of New War on Cancer Marks Many Advances 52259 5First Anniversary of New War on Cancer Marks Many Advances 52259 6First Anniversary of New War on Cancer Marks Many Advances 52259 7Anti epilepsy drug risk on cognitive function for unborn children 52256 1Anti epilepsy drug risk on cognitive function for unborn children 52256 2
...th ("Radius"),announced today that the company has...s internal nonsteroidal selective androgen recepto...reclinical development as a,potential therapy for ...ia),and other musculoskeletal conditions such as o...of promising SARMs after it demonstrated exception...
...peutics,Inc. (Nasdaq: HALO ), a biopharmaceutical...argeting the extracellular matrix, today,announced...tus program at,the American Diabetes Association,s...mbining the company,s proprietary recombinant huma... (regular insulin human) or,Humalog(R) (insulin li...
Other Medicine Technology:Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5
Optima 38/SP
Optima FW
Hertel
Exophthalmometer, Hertel
Medicine Products: